Blueprint Medicines
FDA Approved Drugs

Blueprint Medicines

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified
  • Total Records 6
  • Latest Approval Date Jun 16, 2021
  • Data Source FDA
  • First Approval Date Jan 09, 2020
All
6
View
Unclassified
1
View
RX
5
View
Company Overview

Company

Blueprint Medicines

Country

U.S.A

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Blueprint Medicines

Blueprint Medicines 45 Sidney Street Cambridge, MA 02139

U.S.A

www.blueprintmedicines.com:443/ info@blueprintmedicines.com View on Map
FDA Approved Drug Records ( 6 records )
2020
09 Jan
RX Application: 212608

Drug Name

AYVAKIT

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2020-01-09

212608 / 1

Active Ingredient

AVAPRITINIB

Application Number

212608

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2020-01-09

Regulatory Status

RX

2020
09 Jan
RX Application: 212608

Drug Name

AYVAKIT

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2020-01-09

212608 / 2

Active Ingredient

AVAPRITINIB

Application Number

212608

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2020-01-09

Regulatory Status

RX

2020
09 Jan
RX Application: 212608

Drug Name

AYVAKIT

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2020-01-09

212608 / 3

Active Ingredient

AVAPRITINIB

Application Number

212608

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2020-01-09

Regulatory Status

RX

2021
16 Jun
RX Application: 212608

Drug Name

AYVAKIT

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2021-06-16

212608 / 4

Active Ingredient

AVAPRITINIB

Application Number

212608

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2021-06-16

Regulatory Status

RX

2021
16 Jun
RX Application: 212608

Drug Name

AYVAKIT

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2021-06-16

212608 / 5

Active Ingredient

AVAPRITINIB

Application Number

212608

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2021-06-16

Regulatory Status

RX

-
Unclassified Application: 214701

Drug Name

GAVRETO

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

214701 / 1

Active Ingredient

PRALSETINIB

Application Number

214701

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    6 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AYVAKIT

Application Number

212608

Product Number

1

Active Ingredient

AVAPRITINIB

Dosage Form

-

Strength

100MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.